AMANDA MERRITT: Open Payments
NPI 1679801534 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,032 in 135 payments from 32 companies in 2025. Trend: 2023 $3,370 · 2024 $4,618 · 2025 $3,032
Food & beverage: $2,707Consulting: $325
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $520 |
| UCB, Inc. | 17 | $383 |
| Biogen, Inc. | 6 | $263 |
| Lundbeck LLC | 11 | $197 |
| Alexion Pharmaceuticals, Inc. | 2 | $194 |
| Lilly USA, LLC | 5 | $177 |
| Novartis Pharmaceuticals Corporation | 9 | $153 |
| Neurelis, Inc. | 4 | $105 |
| Mallinckrodt Hospital Products Inc. | 4 | $97 |
| EMD Serono, Inc. | 3 | $96 |
Products named: TYSABRI, ULTOMIRIS, BOTOX, UBRELVY, KISUNLA, Fintepla, KESIMPTA, REXULTI.
Industry payments across GA — which companies pay providers there.
